Anna Gluskin
Direktor/Vorstandsmitglied bei EASTGATE BIOTECH CORP.
Aktive Positionen von Anna Gluskin
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
EASTGATE BIOTECH CORP. | Direktor/Vorstandsmitglied | - | - |
Vorstandsvorsitzender | 22.05.2012 | - | |
Vorsitzender | 22.05.2012 | - | |
Eastgate Pharmaceuticals, Inc.
Eastgate Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Eastgate Pharmaceuticals, Inc. operates as a pharmaceutical research and product company. The company is headquartered in North York, Canada. | Vorstandsvorsitzender | 01.03.2011 | - |
Karriereverlauf von Anna Gluskin
Ehemalige bekannte Positionen von Anna Gluskin
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
NUGENEREX IMMUNO-ONCOLOGY, INC. | Direktor/Vorstandsmitglied | 14.01.2011 | 14.01.2011 |
Generex Pharmaceuticals, Inc.
Generex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Generex Biotechnology Corp., Generex Pharmaceuticals, Inc. provides pharmaceutical products. The company is based in Toronto, Canada. | Direktor/Vorstandsmitglied | 14.01.2011 | 14.01.2011 |
PROTECT PHARMACEUTICAL CORPORATION | Direktor/Vorstandsmitglied | 02.07.2010 | 01.09.2010 |
GENEREX BIOTECHNOLOGY CORPORATION | Vorstandsvorsitzender | 01.11.1995 | 01.09.2010 |
Gründer | 01.11.1995 | 01.09.2010 | |
Präsident | 01.11.1995 | 01.09.2010 | |
Interlock Consolidated Enterprises, Inc. | Direktor/Vorstandsmitglied | - | - |
Ausbildung von Anna Gluskin
Moscow State University Lomonosov | Graduate Degree |
University of Toronto | Graduate Degree |
Statistik
International
Kanada | 6 |
Vereinigte Staaten | 4 |
Russland | 2 |
Operativ
Director/Board Member | 5 |
Chief Executive Officer | 3 |
Graduate Degree | 2 |
Sektoral
Health Technology | 6 |
Consumer Services | 3 |
Transportation | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
PROTECT PHARMACEUTICAL CORPORATION | Transportation |
EASTGATE BIOTECH CORP. | Health Technology |
Private Unternehmen | 5 |
---|---|
Generex Pharmaceuticals, Inc.
Generex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Generex Biotechnology Corp., Generex Pharmaceuticals, Inc. provides pharmaceutical products. The company is based in Toronto, Canada. | Health Technology |
NuGenerex Immuno-Oncology, Inc.
NuGenerex Immuno-Oncology, Inc. BiotechnologyHealth Technology NuGenerex Immuno-Oncology, Inc. is an oncology company focuses on the modulation of the immune system to treat cancer. It develops immunotherapeutic products and vaccines based on proprietary, patented platform technology, Ii-Key. The Ii-Key is a peptide derived from the major histocompatibility complex (MHC) class II associated invariant chain that regulates the formation, trafficking, and antigen-presenting functions of MHC class II complexes, essential for the activation of T cells in the immune response. The company was founded on October 8, 1993 and is headquartered in Miramar, FL. | Health Technology |
Eastgate Pharmaceuticals, Inc.
Eastgate Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Eastgate Pharmaceuticals, Inc. operates as a pharmaceutical research and product company. The company is headquartered in North York, Canada. | Health Technology |
Interlock Consolidated Enterprises, Inc. | |
Generex Biotechnology Corp.
Generex Biotechnology Corp. Pharmaceuticals: MajorHealth Technology Generex Biotechnology Corp. is an integrated healthcare holding company with end-to-end solutions for patient centric care from rapid diagnosis through delivery of personalized therapies. It builds new kind of healthcare company, which provides support to physicians in an MSO network, and ongoing relationships with patients to improve the patient experience and access to optimal care. The company was founded by Rose C. Perri on September 4, 1997 and is headquartered in Miramar, FL. | Health Technology |
- Börse
- Insiders
- Anna Gluskin
- Erfahrung